SCM
Sio Capital Management Portfolio holdings
AUM
$395M
1-Year Est. Return
196.27%
1 Year Est. Return
+196.27%
AUM
$395M
AUM Growth
+$146M
(+59%)
Holding
66
Top Buys
| 1 | +$38.9M | |
| 2 | +$20.2M | |
| 3 | +$17.7M | |
| 4 |
Henry Schein
HSIC
|
+$14.5M |
| 5 |
Kenvue
KVUE
|
+$13.7M |
Top Sells
| 1 | +$19.5M | |
| 2 | +$14.5M | |
| 3 | +$12.7M | |
| 4 |
Annexon
ANNX
|
+$9.83M |
| 5 |
SEPN
Septerna Inc
SEPN
|
+$7.43M |
Sector Composition
| 1 | Healthcare | 83.63% |
| 2 | Industrials | 12.89% |
| 3 | Consumer Staples | 3.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Maximus
MMS
$4.73B
| $50.9M | 12.89% |
557,615
+9,529
|
|
||
2
Celcuity
CELC
$4.64B
| $38.9M | 9.83% |
+786,526
|
|
||
3
Sanofi
SNY
$122B
| $26.6M | 6.72% |
562,703
+375,203
|
|
||
4
Dianthus Therapeutics
DNTH
$1.83B
| $22.7M | 5.75% |
577,750
+341,680
|
|
||
5
Alkermes
ALKS
$4.8B
| $20.2M | 5.12% |
+674,840
|
|
||
6
Disc Medicine
IRON
$3.6B
| $18.8M | 4.76% |
284,787
|
|
||
7
Merck
MRK
$256B
| $14.9M | 3.77% |
177,300
+3,349
|
|
||
|
8
Henry Schein
HSIC
$8.83B
| $14.5M | 3.68% |
+219,207
|
|
||
9
Centene
CNC
$18.8B
| $13.8M | 3.5% |
387,600
+125,100
|
|
||
|
10
Kenvue
KVUE
$33.4B
| $13.7M | 3.47% |
+844,000
|
|
||
11
BioMarin Pharmaceuticals
BMRN
$10.6B
| $12.2M | 3.09% |
225,114
|
|
||
12
GSK
GSK
$96.2B
| $11.6M | 2.94% |
+268,873
|
|
||
|
DRUG
13
Bright Minds Biosciences
DRUG
$498M
| $11.6M | 2.93% |
190,764
-321,574
|
|
||
14
Haemonetics
HAE
$3.83B
| $9.65M | 2.44% |
+198,035
|
|
||
15
Aquestive Therapeutics
AQST
$744M
| $8.37M | 2.12% |
1,498,095
+550,606
|
|
||
16
KalVista Pharmaceuticals
KALV
$682M
| $8.33M | 2.11% |
+683,819
|
|
||
|
AVR
17
Anteris Technologies
AVR
$167M
| $7.98M | 2.02% |
1,772,601
-66,421
|
|
||
18
Crinetics Pharmaceuticals
CRNX
$4.27B
| $7.28M | 1.84% |
+174,841
|
|
||
19
Tyra Biosciences
TYRA
$1.13B
| $7.2M | 1.82% |
514,947
-295,327
|
|
||
|
RAPP
20
Rapport Therapeutics
RAPP
$1.38B
| $5.5M | 1.39% |
+185,265
|
|
||
21
NovoCure
NVCR
$1.36B
| $5.35M | 1.35% |
+413,829
|
|
||
22
ANI Pharmaceuticals
ANIP
$1.9B
| $5.1M | 1.29% |
55,723
-57,200
|
|
||
23
Edgewise Therapeutics
EWTX
$2.73B
| $4.98M | 1.26% |
307,181
-232,549
|
|
||
24
Teleflex
TFX
$5.14B
| $4.9M | 1.24% |
+40,057
|
|
||
25
Simulations Plus
SLP
$337M
| $4.83M | 1.22% |
+320,307
|
|